BCG-MEDAC

This brand name is authorized in Austria, Estonia, Finland, France, Croatia, Ireland, Lithuania, Malta, Netherlands, Poland, Romania, United States

Active ingredients

The drug BCG-MEDAC contains one active pharmaceutical ingredient (API):

1 BCG vaccine UNII 2XQ558L16Z - BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN

BCG vaccine is an immunostimulating agent. It has anti-tumor activity, but the exact mechanism of action is not known. Read about BCG vaccine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L03AX03	BCG vaccine	L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AX Other immunostimulants
Discover more medicines within L03AX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1127900, 1129946, 1129957, 1140725, 1140736, 1603707, 1848045, 1852893
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 018718
Country: FR	Base de données publique des médicaments	Identifier(s): 60973899
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1011850, 1018905, 1065180, 1065181
Country: MT	Medicines Authority	Identifier(s): AA565/20602
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100119519
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W13958001, W13958002, W13958003, W13958004, W13958005, W13958006, W13958007, W13958008
Country: US	FDA, National Drug Code	Identifier(s): 0052-0603